Home›People›Brian Slingsby, M.D., Ph.D., M.P.H.
BH

Brian Slingsby, M.D., Ph.D., M.P.H.

Director at Arialys Therapeutics.

Director
Updated Nov 2, 2026·Latest SEC filing Jul 1, 2025·Suggest an edit

About Brian Slingsby, M.D., Ph.D., M.P.H.

Brian Slingsby, M.D., Ph.D., M.P.H. is a director at Arialys Therapeutics.

Brian Slingsby, M.D., Ph.D., M.P.H. first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Brian Slingsby, M.D., Ph.D., M.P.H. in the role, so the role may have started earlier or lasted longer.

Arialys Therapeutics, Inc.
Director
2022 – 2025 · LA Jolla, CA

Key Colleagues at Startups

The people Brian Slingsby, M.D., Ph.D., M.P.H. works with at each company, as listed on that company's latest Form D.

Arialys Therapeutics, Inc. · Form D, Jul 1, 2025
PD
Peter Flynn, Ph.D.
Chief Executive Officer and director
EH
Ed Hurwitz
Director

Sources

  1. SECArialys Therapeutics, Inc. Form D, filed Jul 1, 2025